PureCircle Limited | Int...esults | FE InvestEgate

Report 0 Downloads 64 Views
3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

PureCircle Limited

Interim Results RNS Number : 4720H PureCircle Limited 16 March 2015  

PureCircle  Limited ("PureCircle"  or  the  "Company") Interim  results  for  the  six  months  ended  31  December  2014 PureCircle   (LSE:   PURE)   the   world's   largest   producer   and   marketer   of   high   purity   stevia   today   announces   its unaudited  interim  results  for  the  six  month  period  from  1  July  2014  to  31  December  2014  ("1H  FY  15").   The   unaudited   financial   statements   comprising   the   profit   and   loss   and   cashflow   statements   for   the  six  months to  31  December  2014  ("1H  FY15")  along  with  the  balance  sheet  as  at  31  December  2014  are  set  out  below, together   with   the   unaudited   profit   and   loss   and   cashflow   comparatives   for   the   six   months   to   31   December 2013  ("1H  FY14").   SUMMARY  FINANCIALS Period  ended  31  December    (US$m)

1H  FY15

1H  FY14

Change

Sales Gross  margin Operating  profit** EBITDA** Net  result  after  tax

43.2 14.5 3.5 6.4 (0.9)

34.9 12.3 2.9 5.2 (1.9)

24% 18% 21% 24% 53%

Net  debt Net  assets Net  assets  per  share  (US  cents)

(52) 188 1.1

(85) 141 0.9

39% 33% 29%

  **              Operating  profit  and  EBITDA  are  as  per  segmental  reporting  on  page  13.  The  full  profit  and  loss  account  is  detailed  on  page  4.

   Sales:  Sales  of  $43m  increased  24%  over  1H  FY14  ($35m).  There  was  growth  in  sales  in  all  of  our  global  sales regions. Gross  margin:   Gross   margin   increased   18%   to   $14.5m.   Gross   margin   %   of   34%   was   consistent   with   1H   FY14 (35%). EBITDA:  EBITDA   increased   24%   in   line   with   sales   revenues   to   $6.4m.   EBITDA   improvements   are   after   $1.5m increased   SG&A   investment   in   PCL's   operational   management   and   global   customer   service   infrastructure, including  in-­‐region  application  capacity,  to  support  anticipated  future  sales  growth. Net  Result  after  Tax:  1H  FY15  net  result  of  ($0.9m)  represented  a  $1m  (53%)  improvement  on  1H  FY14.  The net   result   reflects   $1.2m   improved   EBITDA,   $0.6m   increased   Long   Term   Incentive   Plan   (LTIP)   costs,   $3m adverse  foreign  exchange  movements  and  $3.8m  favourable  interest  and  tax. Net  debt:  Net  debt  of  $52m  is  $33m  lower  than  the  $85m  at  31  December  2013.  This  reflects  $43m  November 2014   placement   proceeds,   offset   by   increases   in   inventory   production   ahead   of   anticipated   H2   and   FY16   sales growth. During  1H  FY15  the  Group  successfully  restructured  its  principal  bank  facilities.  $20m  of  debt  was  repaid  a  year early  and  the  balance  refinanced  onto  a  new  $71m  5  year  facility  (to  September  2019)  at  a  3%  lower  interest rate.   http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

1/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

Share  Placement:  In  November  2014  the  Group  issued  5  million  new  ordinary  shares  at  GBP  5.50  per  share raising  $43m  to  fund  expansion  of  its  production  capacity,  described  in  more  detail  below.

  Interim  results  for  the  six  months  ended  31  December  2014  (continued)   BUSINESS  DEVELOPMENTS   Market:  Since   the   end   of   FY14   the   Stevia   market   has   seen   an   unparalleled   series   of   milestone   F&B   product launches  and  roll-­‐outs  integrating  stevia  into  mainstream  products.  High  profile  Cola  roll-­‐outs  led  by  Coca-­‐Cola Life,   Pepsi   Next   and   Pepsi   True   into   major   markets   like   the   USA,   Mexico,   UK,   France,  Japan  and  other  markets and   reformulations   across   a   range   of   leading   carbonated   Lemon   Lime,   Orange   and   other   brands   indicate clearly   that   stevia   is   now   seen   as   a   mainstream   sweetener   of   choice   in   the   Carbonated   Soft   Drink   (CSD) category.   The   period   has   also   seen   a   wide   range   of   stevia   sweetened   product   launches   from   major   retailers across   Europe   and   America   and   iconic   brand   adoption   in   categories   as   diverse   as   Ketchups,   Yogurts   and Confectionery.   Global  brand  adoption  has  been  mirrored  with  growth  in  product  launches  by  large  regional  F&B  brands  across the  world:  from  Chile  in  the  South  to  Finland  in  the  North  and  from  Japan,  China,  and  Philippines  in  the  East  to Mexico   in   the   West.   Mintel   reports   2,274   new   product   launches   in   2014   taking   5   year   launches   over   6,000. Mintel  report  that  food  product  adoption  exceeded  beverages  by  number,  confirming  the  widening  usage  of stevia   as   a   mainstream   ingredient.   With   4   billion   consumers   now   having   regulatory   access   to   stevia,   market estimates   suggest   that   the   current   footprint   of   products   already   launched   using   stevia   has   the   potential   to support  billion  dollar  industry  when  existing  launches  are  rolled  out  fully  across  the  next  10+  years.   Innovation:   PureCircle   continues   to   lead   stevia   innovation   with   new   products   and   applications   designed   to meet   identified   market   needs   and   unlock   further   demand   to   help   moderate   calories   naturally.   1H   FY15   saw important  developments  including  the  successful  launch  of  Sigma  D,  which  has  excellent  application  properties in   the   dairy   sector,   and   further   developments   within   our   proprietary   flavor   systems.   Each   of   our   new developments  continue  to  grow  overall  market  usage  and  strengthen  further  our  market  share.   With  our  strong  diversified  customer  base,  our  unique  breadth  of  product  innovation  and  application  support and  our  global  supply  chain  and  customer  support  infrastructure  already  established  PureCircle  continues  to retain  and  build  further  market  leadership.    

  Production   capacity   expansion:   With   the   prospects   of   sustained   long   term   market   growth,   PureCircle   has started   to   expand   its   production   capacity   so   as   to   meet   anticipated   future   increased   volume   demand   and further  sustain  market  share  and  its  first  mover  advantage.  The  PureCircle  Board  has  approved  $42m  of  capital expenditure   projects   that   will   increase   production   capacity   of   refined   stevia   sweeteners   and   natural   flavor systems  and  provide  additional  investment  in  next  generation  stevia  innovation.   It   is   expected   that   $34m   of   the   investment   will   be   for   production   capacity   expansion   to   come   on   stream  in FY17   with   the   balance   of   $8m   supporting   innovation   projects   through   FY18.   The   $42m   investment   will   be funded  from  the  $43m  November  2014  Placement  proceeds  described  earlier.   The   production   capacity   expansion   will   be   centred   on   the   Group's   existing   Malaysia   and   China   production facilities.   Leaf:  with   growth   in   end   consumer   demand,   leaf   supply   has   tightened.   Prices   in   China   have   increased   year   on year.   We   are   actively   managing   this   long   term   through   leading   the   diversification   of   leaf   supply   outside   China. But  in  the  short  term  higher  leaf  prices  will  increase  cost  of  sales.      

Interim  results  for  the  six  months  ended  31  December  2014  (continued)   Sustainability:  In  January  PureCircle  issued  the  industry's  first  sustainability  report.  The  report  demonstrates the   efficient   carbon   and   water   footprint   of   stevia   relative   to   other   major   sweeteners   and   tracks   progress against   the   Company's   social   and   environmental   goals.   The   full   report   may   be   downloaded   at http://purecircle.com/company/corporate-­‐social-­‐responsibility/     Management  and  systems:  To  support  management  of  growth,  in  1H  FY15  we  strengthened  our  management with   the   appointment   of   Jordi   Ferre   as   Chief   Operating   Officer   and   implemented   an   Operating   Committee reporting  to  him  with  key  new  hires  in  Manufacturing,  Leaf  Development,  HR  and  Planning.  At  the  same  time we   have   strengthened   management   in   each   of   our   key   Commercial   regions.   We   also   implemented   the   first stages  of  Group  ERP  information  systems.     http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

2/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

Outlook:  Commenting  on  the  1H  FY15  trading,  the  Group  CEO  Magomet  Malsagov  said:    the  size  and  breadth of   F&B   product   launches   and   roll-­‐outs   in   1H   FY15   indicate   that   stevia   is   well   on   the   way   to   becoming   an important   ingredient   for   F&B   companies   wishing   to   moderate   calories.   Further   the   existing   footprint   of products  launched  using  stevia  provides  a  sound  basis  for  a  multi-­‐billion  $  stevia  industry  in  the  years  to  come.   In  1H  FY15  we  again  strengthened  our  position  as  market  leader  with  further  proprietary  product  innovation and   growth   in   both   delivered   sales   and   project   pipelines.   With   sustained   long   term   growth   prospects, PureCircle  has  started  to  expand  our  production  capacity  and  expect  this  to  come  on  stream  in  FY17.   We   are   generating   revenues   from   a   wide   range   of   natural   sweetener   and   flavor   products   and   from   a   wide range   of   customers   directly   and   through   our   business   partners.   With   accelerating   roll-­‐outs   of   food   and beverage   products   using   PureCircle's   stevia   solutions,   particularly   in   the   important   Carbonated   Soft   Drink category,   the   Company   is   confident   of   large   long   term   sales   growth   and   with   it   improvements   in profitability.   However,   until   market   consumption   smooths   out,   that   growth   will   come   with   a   lumpy   sales profile   and   therefore   some   volatility:   this   adds   some   complexity   to   our   ability   to   provide   guidance   in   the   short term.     Magomet  Malsagov,  CEO +603  2166  2066 William  Mitchell,  CFO +44  7974  005  163 RFC  Ambrian  Ltd  (NOMAD) Stephen  Allen  

+61  8  9480  2500

NOTES  TO  EDITORS

PureCircle  is  the  global  leader  in  the  production  of  high  purity  Stevia  sweeteners  and  natural  flavors.  PureCircle  is  leading  the  industry with   the   development   of   a   sustainable,   vertically   integrated   supply   chain   operating   in   four   continents.     Across   these   regions,   PureCircle sources  dry  stevia  leaves,  undertakes  extraction  processes  and  refines  the  extract  into  sweeteners  which  it  markets  as  a  mainstream ingredient  to  Food  and  Beverage  manufacturers  worldwide.  PureCircle  provides  a  sustainable  cash  crop  for  rural  farming  communities  in each  region  and  works  closely  with  these  communities  to  maximize  the  social,  economic,  and  environmental  benefits  of  its  operations. PureCircle's   investment   in   research   and   development   has   given   it   a   leadership   position   in   the   Stevia   industry   and   its   scientists   are globally   recognized   experts   in   their   field.     PureCircle   has   pioneered   the   industry   trust   mark   "Stevia   PureCircle"   that   educates   consumers about  the  benefits  of  Stevia  and  provides  a  strong  base  of  trust  for  both  consumers  and  Food  &  Beverage  companies  alike.  PureCircle also  funds  the  Global  Stevia  Institute  (globalsteviainstitute.com)  which  provides  a  global  platform  for  stevia  education  and  outreach,  led by  internationally  recognized  health  professionals.  PureCircle's  corporate  offices  are  located  in  Chicago,  USA;  Asuncion,  Paraguay;  Kuala Lumpur,   Malaysia;   Ganzhou,   China;   Shanghai,   China   and   Kericho,   Kenya.   PureCircle   is   listed   on   the   London   Stock   Exchange   AiM   market under  the  ticker  symbol:  PURE.    For  more  information  on  PureCircle,  visit:  www.purecircle.com.

 

Condensed  consolidated  statement  of  comprehensive  income for  the  period  ended  31  December  2014                 Unaudited Notes

Six  months  ended 31  December

31  December

2014

2013

USD'000

USD'000

Continuing  operations Revenue

                       43,228

                       34,851

Cost  of  sales

                   (28,435)

                   (22,596)

Gross  profit

                       14,793

                       12,255                            2,057

Other  income

6

                                 148

Other  expenses

7

                       (1,348)

 -­‐

                   (13,693)

                   (11,782)

Administrative  expenses Finance  income

                                       12

                                 180

Finance  costs

                       (3,768)

                       (4,537)

Share  of  loss  of  joint  ventures

                               (516)

                               (532)

                       (4,372)

                       (2,359)

Loss  before  taxation Income  tax  credit Loss  for  the  period

15

                           3,445

                                 470

                               (927)

                       (1,889)

                       (5,646)

                       (1,160)

Other  comprehensive  income  (net  of  tax): Items  that  may  be  reclassified  subsequently  to  profit  or  loss: Exchange  difference  arising  on  translation  of  foreign    operations Share  of  other  comprehensive  income  of  investments  accounted http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

3/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

   for  using  equity  method

                                   (34)

                                   (43)

                       (5,680)

                       (1,203)

                       (6,607)

                       (3,092)

Owners  of  the  company

                               (899)

                       (1,894)

Non-­‐controlling  interest

                                   (28)

                                           5

                               (927)

                       (1,889)

Owners  of  the  company

                       (6,590)

                       (3,106)

Non-­‐controlling  interest

                                   (17)

                                       14

                       (6,607)

                       (3,092)

Total  comprehensive  loss  for  the  period  (net  of  tax) Loss  for  the  financial  period  attributable  to:

Total  comprehensive  loss  attributable  to:

Earnings  per  share  (US  cents) Basic

17

                             (0.54)

                             (1.15)

Diluted

17

                             (0.54)

                             (1.15)

Condensed  consolidated  statement  of  financial  position As  at  31  December  2014 Notes

Unaudited 31 December 2014  USD'000

Audited 30  June 2014 USD'000

Assets Non-­‐current  assets Property,  plant  and  equipment

11

Intangible  assets

11

Biological  assets

13

Prepaid  land  lease  payments Deferred  tax  assets Investment  in  joint  ventures Trade  receivables Other  receivables

                      59,651                       37,818                           3,990                           2,973                           9,282                                  312                                         -­‐                               1,415                  115,441

                      63,715                       38,023                            4,237                            2,999                            5,876                                  149                            1,950                                  553                  117,502

Current  assets Inventories

12

Trade  receivables Other  receivables  and  prepayments Tax  recoverable Cash  and  bank  balances Total  assets

                      96,810                       36,220                           7,547

                      86,519                       37,362                            4,962

                                 501                       58,325                  199,403                  314,844

                                 581                       45,865                  175,289                  292,791

                      16,973                  206,251                       (4,771)                           7,597                  

                      16,472                  163,240

Equity  and  liabilities Equity Share  capital

16

Share  premium

16

Foreign  exchange  translation  reserve Share  option  reserve

http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

                                 920                            5,076                   4/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

Accumulated  losses Equity  attributable  to  owners  of  the  company Non-­‐controlling  interest Total  equity

(39,102)

(38,203)

                 186,948                                  705                  187,653

                 147,505                                  722                  148,227

Non-­‐current  liabilities Long-­‐term  borrowings

                      67,515                                  319                           2,180                       70,014

14

Deferred  income Other  payables  and  accruals

                           2,169                                  360                            2,111                            4,640

Current  liabilities                           5,799                           9,090                       42,288                       57,177

Trade  payables Other  payables  and  accruals Short-­‐term  borrowings

14

Total  liabilities Total  equity  and  liabilities Net  assets  per  share  (USD)

                 127,191                  314,844                                1.11

                           5,879                       10,364                  123,681                  139,924                  144,564                  292,791                                0.90

Condensed  consolidated  statement  of  changes  in  equity as  at  31  December  2014 Attributable  to  owners  of  the  Company Foreign exchange

Share

Non-­‐

Share

Share

translation

option

Accumulated

capital

premium

reserve

reserve

losses

USD'000

USD'000

USD'000

USD'000

16,472

163,240

920

Loss  for  the  period

-­‐

-­‐

Other  comprehensive income

-­‐

-­‐

Total  comprehensive  loss for    the  period  (net  of  tax)

-­‐

-­‐

Share  option  scheme compensation  expense granted  during  the  period

-­‐

Balance  at  1  July  2014

Issuance  of  shares

controlling

Total

Sub-­‐ total

interest

equity

USD'000

USD'000

USD'000

USD'000

5,076

(38,203)

147,505

722

148,227

-­‐

-­‐

(899)

(899)

(28)

(927)

(5,691)

-­‐

-­‐

(5,691)

11

(5,680)

(5,691)

-­‐

(899)

(6,590)

(17)

(6,607)

-­‐

-­‐

2,570

-­‐

2,570

-­‐

2,570

-­‐

-­‐

-­‐

43,463

-­‐

43,463

(39,102)

186,948

705

187,653

500

42,963

Exercise  of  share  options

1

48

Balance  at  31  December 2014

16,973

206,251

(49) (4,771)

7,597

   Condensed  Consolidated  Statement  of  Changes  in  Equity  as  at  31  December  2013 Attributable  to  owners  of  the  Company Foreign exchange

Share

Non-­‐

Share

Share

translation

option

Accumulated

capital

premium

reserve

reserve

losses

USD'000

USD'000

USD'000

USD'000

USD'000

http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

controlling

Total

Sub-­‐total

interest

equity

USD'000

USD'000

USD'000

5/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate Balance  at  1  July  2013

16,460

162,898

Loss  for  the  period

-­‐

Other  comprehensive  income

-­‐

Total  comprehensive  loss  for   the  period  (net  of  tax) Share  option  scheme compensation  expense granted  during  the  period Exercise  of  share  options Balance  at  31  December  2013

 

1,432

1,530

(40,519)

141,801

715

142,516

-­‐

-­‐

-­‐

(1,894)

(1,894)

5

(1,889)

-­‐

(1,212)

-­‐

-­‐

(1,212)

9

(1,203)

-­‐

-­‐

(1,212)

-­‐

(1,894)

(3,106)

14

(3,092)

-­‐

-­‐

-­‐

1,522

-­‐

1,522

-­‐

1,522

2

41

-­‐

(43)

-­‐

-­‐

-­‐

-­‐

16,462

162,939

220

3,009

(42,413)

140,217

729

140,946

 

Condensed  consolidated  cash  flow  statement  for  the  period  ended  31 December  2014 Unaudited  6  months  ended 31 31 December December 2014 2013 USD'000 USD'000 CASH  FLOWS  FOR  OPERATING  ACTIVITIES Loss  before  taxation

(4,372)

(2,359)

Adjustments  for:-­‐ Amortisation  of  deferred  income Amortisation  of  prepaid  land  lease  payments Depreciation  of  property,  plant  and  equipment Interest  expense Interest  income Share  based  payments Amortisation  of  intangible  assets Inventories  written  off Intangible  assets  written  off Unrealised  exchange  loss/(gain) Share  of  loss  in  joint  ventures

(49) 73 2,893 3,768 (12) 2,570 113 12 47 1,922 516

(21) 70 2,927 4,537 (180) 1,522 40 4 -­‐ (1,250) 532

Operating  cash  flow  before  working  capital  changes

7,481

5,822

(10,044) (355) (1,930)

(4,038) 1,428 (5,205)

NET  CASH  FOR  OPERATIONS

(4,848)

(1,993)

Interest  received Interest  paid Tax  refund/(paid) NET  CASH  FOR  OPERATING  ACTIVITIES

12 (3,768) 101 (8,503)

180 (4,537) (121) (6,471)

(1,964) (50) (1,411) 1 (342) (3,766) (12,269)

(2,708) -­‐ (3,436) -­‐ (336) (6,480) (12,951)

Increase  in  inventories (Increase)/decrease    in  trade  and  other  receivables Decrease  in  trade  and  other  payables

CASH  FLOWS  FOR  INVESTING  ACTIVITIES Addition  of  intangible  assets Addition  of  leasehold  land Addition  of  property,  plant  and  equipment Proceeds  from  disposal  of  property,  plant  and  equipment Investment  in  joint  venture NET  CASH  FOR  INVESTING  ACTIVITIES BALANCE  CARRIED  FORWARD

  http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

6/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

           

Condensed  consolidated  cash  flow  statement  for  the  period  ended  31 December  2014  (continued) Unaudited  6  months  ended 31  December 31  December 2014 2013 USD'000 USD'000

BALANCE  BROUGHT  FORWARD

(12,269)

(12,951)

43,463 105,101 (123,047) (19) 7,589

-­‐ 17,066 (22,194) (19) (36)

33,087

(5,183)

(769)

(232)

38,014

46,605

58,063

28,239

58,325 (262) 58,063

30,589 (2,350) 28,239

CASH  FLOWS  FOR  FINANCING  ACTIVITIES Placement  of  shares Drawdown  of  borrowings Repayment  of  borrowings Net  repayment  of  hire  purchase Decrease/(increase)  in  restricted  cash NET  CASH  FROM/(FOR)  FINANCING  ACTIVITIES Effects  of  foreign  exchange  rate  changes  on cash  and  cash  equivalents CASH  AND  CASH  EQUIVALENTS AT  BEGINNING  OF  THE  FINANCIAL  PERIOD CASH  AND  CASH  EQUIVALENTS  AT  END  OF  THE FINANCIAL  PERIOD GROSS  CASH LESS:  RESTRICTED  CASH CASH  AND  CASH  EQUIVALENTS

       

  Notes  to  interim  financial  statements 1.        General  information   The   Company   was   incorporated   and   registered   as   a   private   limited   company   in   Bermuda,   under   the   Companies (Bermuda)   Law   1991   (as   amended).     The   Company   has   its   primary   listing   on   the   AIM   market   operated   by   the London  Stock  Exchange,  plc  (AIM).   The  Company  is  engaged  principally  in  the  business  of  investment  holding  whilst  the  principal  activities  of  the  rest of  the  Group  are  the  production,  marketing  and  distribution  of  natural  sweeteners  and  flavours. The  unaudited  condensed  consolidated  interim  financial  statements  have  been  authorised  for  issue  by  the  Board  of Directors  on  16  March  2015.    

2.                Basis  of  preparation   The  condensed  consolidated  interim  financial  statements  for  the  six  months  ended  31  December  2014  have  been prepared  in  accordance  with  IAS  34,  "Interim  financial  reporting".    In  preparing  these  condensed  interim  financial statements,   the   significant   judgments   and   estimates   made   by   management   in   applying   the   Group's   accounting policies  were  the  same  as  those  that  applied  to  the  consolidated  financial  statements  for  the  year  ended  30  June http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

7/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

2014.  The   condensed   consolidated   interim   financial   statements   should   be   read   in   conjunction   with   the   Group's annual   financial   statements   for   the   year   ended   30   June   2014   ("FY2014"),   which   have   been   prepared   in   accordance with  IFRSs.    

3.                Accounting  policies The  accounting  policies  adopted  for  1H  FY2015  are  as  stated  in  the  Group's  FY2014  financial  statements,  with  the addition  of  new  standards  and  amendments  to  standards  that  are  mandatory  for  the  financial  year  beginning  1  July 2014,  the  new  standards  are  summarised  below: (i)    Financial  year  beginning  on/after  1  July  2014   · Amendment   to   IAS   32,   'Financial   Instruments:   Presentation'   does   not   change   the   current   offsetting   model in  IAS  32.  It  clarifies  the  meaning  of  'currently  has  a  legally  enforceable  right  of  set-­‐off'  that  the  right  of  set-­‐ off  must  be  available  today  (not  contingent  on  a  future  event)  and  legally  enforceable  for  all  counterparties in  the  normal  course  of  business.  It  clarifies  that  some  gross  settlement  mechanisms  with  features  that  are effectively  equivalent  to  net  settlement  will  satisfy  the  IAS  32  offsetting  criteria.   · Amendments   to   IFRS   10,   IFRS   12   and   IAS   27   introduce   an   exception   to   consolidation   for   investment entities.  Investment  entities  are  entities  whose  business  purpose  is  to  invest  funds  solely  for  returns  from capital  appreciation,  investment  income  or  both  and  evaluate  the  performance  of  its  investments  on  fair value   basis.   The   amendments   require   investment   entities   to   measure   particular   subsidiaries   at   fair   value instead  of  consolidating  them.   ·

Amendment  to  IFRS  2  'Share-­‐based  Payment'  clarifies  the  definition  of  'vesting  conditions'  by  separately defining   'performance   condition'   and   'service   condition'   to   ensure   consistent   classification   of   conditions attached  to  a  share-­‐based  payment.

       

Notes  to  interim  financial  statements  (continued)  

4.                Accounting  policies  (continued) The  accounting  policies  adopted  for  1H  FY2015  are  as  stated  in  the  Group's  FY2014  financial  statements,  with  the addition  of  new  standards  and  amendments  to  standards  that  are  mandatory  for  the  financial  year  beginning  1  July 2014,  the  new  standards  are  summarised  below  (continued): (i)    Financial  year  beginning  on/after  1  July  2014  (continued)   · Amendment   to   IFRS   8   "Operating   Segments"   requires   disclosure   of   the   judgements   made   by   management in   aggregating   operating   segments.   This   includes   a   description   of   the   segments   which   have   been aggregated   and   the   economic   indicators   which   have   been   assessed   in   determining   that   the   aggregated segments  share  similar  economic  characteristics.   The  standard  is  further  amended  to  require  a  reconciliation  of  segment  assets  to  the  entity's  assets  when segment  assets  are  reported. ·

Amendment   to   IFRS   13   "Fair   Value   Measurement"   relates   to   the   Basis   for   Conclusions   which   is   not   an integral   part   of   the   Standard.   The   Basis   for   Conclusions   clarifies   that   when   International   Accounting Standards   Board   (IASB)   issued   IFRS   13,   it   did   not   remove   the   practical   ability   to   measure   short-­‐term receivables  and  payables  with  no  stated  interest  rate  at  invoice  amounts  without  discounting,  if  the  effect of  discounting  is  immaterial.  

·

   

Amendment  to  IAS  24  "Related  Party  Disclosures"  extends  the  definition  of  'related  party'  to  include  an entity,  or  any  member  of  a  group  of  which  it  is  a  part,  that  provides  key  management  personnel  services  to the  reporting  entity  or  to  the  parent  of  the  reporting  entity.  

The   adoption   of   the   above   standards   and   interpretations   does   not   have   any   material   impact   on   the   interim financial  statements  in  the  period  of  initial  application.

5.                Fair  value  estimation   Assets  and  liabilities  measured  at  fair  value  can  be  determined  based  on  valuation  methods  as  defined  in  the  fair value  measurement  hierarchy  as  follows: (i)      Quoted  prices  (unadjusted)  in  active  markets  for  identical  assets  or  liabilities  (Level  1). (ii)    Inputs  other  than  quoted  prices  included  within  Level  1  that  are  observable  for  the  asset  or  liability,  either directly  (that  is,  as  prices)  or  indirectly  (that  is,  derived  from  prices)  (Level  2). (iii)  Inputs   for   the   asset   or   liability   that   are   not   based   on   observable   market   data   (that   is,   unobservable   inputs) (Level  3). http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

8/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

  The  Group's  biological  assets  are  measured  at  fair  value  less  cost  to  sell  and  classified  as  Level  3  of  which  valuation inputs  are  not  based  on  observable  market  data  as  management  considers  that  the  costs  of  the  biological  assets approximate  fair  value  as  little  biological  transformation  has  taken  place  since  initial  cost  incurrences,  and  expect that  the  impact  of  the  biological  transformation  on  price  is  not  expected  to  be  material.   There  are  no  other  assets  and  liabilities  of  the  Group  which  are  measured  at  fair  value.  The  carrying  values  of  the financial  assets  and  liabilities  of  the  Group  at  the  balance  sheet  date  approximated  their  fair  values.

Notes  to  interim  financial  statements  (continued)  

6.                Other  income   Other  income  represents  net  foreign  exchange  gain  and  other  miscellaneous  income.

    7.                  Other  expenses   Other  expenses  represent  net  foreign  exchange  loss  and  other  operating  expenses.    

8.                Principal  risks  and  uncertainties

  The   Group   set   out   in   its   FY2014   Annual   Report   and   Financial   Statements   the   financial   risks   including   foreign currency   risk,   interest   rate   risk,   credit   risk,   liquidity   and   cash   flow   risks   and   capital   risk   management   that   could impact   its   performance;   these   remain   unchanged   since   the   Annual   Report   was   published.   The   Group   operates   a structured   risk   management   process,   which   identifies   and   evaluates   risks   and   uncertainties   and   reviews   mitigation activity.    

9.                Seasonality

  At  31  December  2014  the  Group  had  gross  cash  of  USD58  million  (30  June  2014:  USD46  million)  and  net  debt  of USD52  million  (30  June  2014:  USD80  million).  Net  debt  is  defined  as  short-­‐term  and  long-­‐term  borrowings  less  cash and   bank   balances.     The   Group's   sales   are   seasonally   weighted   towards   the   H2   of   each   year   and   net   debt   is expected   to   reduce   over   time   as   sales   increase   and   then   convert   to   cash.   At   31   December   2014,   the   Group   had more  than  USD76  million  cash  and  banking  facilities  headroom.  The  Directors  believe  the  banking  facilities  to  be sufficient  for  projected  funding  requirements.    

10.            Segmental  information  

Management   determines   the   Group's   operating   segments   based   on   the   criteria   used   by   the   Chief   Operating Decision   Maker   who   has   been   identified   as   the   Chief   Executive   Officer   (CEO)   for   making   strategic   decisions.   Management  considers  the  Group  to  be  a  single  operating  segment  whose  activities  are  the  production,  marketing and  distribution  of  natural  sweeteners  and  flavors.   From   a   geographical   perspective,   the   Group   is   a   multinational   with   operations   located   on   all   continents,   but managed  as  one  unified  global  organization.    

Notes  to  interim  financial  statements  (continued)     10.            Segmental  information  (Cont'd)   31  December 2014

31  December 2013

USD'000

USD'000

Revenue Cost  of  sales Gross  profit

43,228 (28,735) 14,493

34,851 (22,596) 12,255

Other  income Administrative  expenses Operating  profit

160 (11,156) 3,497

305 (9,665) 2,895

(2,811) (1,074) (3,768) (216) 3,445

(2,242) 2,057 (4,537) (532) 470

Other  expenses Foreign  exchange  (loss)/gain Finance  costs Share  of  loss  in  joint  ventures Taxation

http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

9/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate Loss  for  the  financial  period

(927)

(1,889)

EBITDA

6,393

5,175

6,393 (2,570) (246) (1,074) (3,768) 3,445 (28) (3,079) (927)

5,175 (1,522) (500) 2,057 (4,537) 470 5 (3,037) (1,889)

Reconciliation  of  Adjusted  EBITDA  to  loss  for  the  financial  year EBITDA Share  based  payment Others Foreign  exchange  (loss)/gain Finance  costs Taxation Non-­‐controlling  interest Depreciation  and  amortisation Loss    for  the  financial  period

  Under  segmental  reporting,  share  of  loss  in  joint  venture  includes  Group's  realised  profit  amounting  to  USD  0.3  million, arising  from  its  sales  to  the  joint  ventures.  Under  the  statement  of  comprehensive  income,  the  profit  is  included  within the  gross  profit  line.

Notes  to  interim  financial  statements  (continued)     10.            Segmental  information  (Cont'd)   31  December Cash  Flow Operating  cash  flow  before  working  capital  changes Increase  in  inventories

31  December

2014

2013

USD'000

USD'000

7,481

5,822

(10,044)

(4,038)

(Increase)/decrease  in    receivables

(355)

1,428

Decrease  in  payables

(1,930)

(5,205)

Net  cash  for  operations

(4,848)

(1,993)

Net  cash  from/(for)  financing  activities

33,087

(5,183)

Gross  cash  at  end  of  the  financial  period

58,325

30,589

31  December

30  June

2014

2014

Statement  of  Financial  Position

USD'000

USD'000

Property,  plant  and  equipment

59,651

63,715

Inventories

96,810

86,519

Third  party  trade  receivables

26,091

29,107

Trade  receivables  from  jointly  controlled  entities

10,129

10,205

Cash  and  bank  balances

58,325

45,865

Total  assets

314,844

292,791

Borrowings

109,803

125,850

51,478

79,985

Net  debt

      Geographical  information  

Bermuda USD'000

Asia USD'000

Europe USD'000

Americas USD'000

Goodwill USD'000

Total USD'000

-­‐ 725

9,622 98,092

4,851 2,007

28,755 12,811

-­‐ 1,806

43,228 115,441

-­‐ 1,577

7,879 100,894

3,144 1,624

23,828 11,601

-­‐ 1,806

34,851 117,502

31  December  2014 Sales Non-­‐current  assets 31  December  2013 Sales Non-­‐current  assets

    The  primary  performance  indicators  used  by  the  Group  are  revenues,  gross  profit,  EBITDA,  net  cash  from  operations  and http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

10/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

net  debt.      

Notes  to  interim  financial  statements  (continued)     10.            Segmental  information  (Cont'd)  

EBITDA   is   calculated   as   EBITDA   adjusted   to   exclude   discretionary   items   such   as   share   based,   bonus,   foreign exchange  gain/losses  and  any  other  non-­‐recurring  expenses.   The  entity  is  domiciled  in  Bermuda.  The  entity's  non-­‐current  assets  are  located  in  countries  other  than  Bermuda. There  is  no  revenue  from  Bermuda.  

11.            Property,  plant  and  equipment  and  intangible  assets  

During  the  period,  the  Group  invested  USD1.4  million  in  property,  plant  and  equipment.   The  addition  to  intangible  assets  is  in  respect  of  capitalisation  of  project  developments  during  the  period,  net  of amortisation  for  products  now  launched  commercially.  

12.            Inventories   31  December

30  June

2014

2014

USD'000

USD'000

Raw  materials

14,343

14,422

Work-­‐in-­‐progress

18,030

11,898

Finished  goods

64,437

60,199

96,810

86,519

    13.            Biological  assets   As  at  31  December  2014,  total  biological  assets  of  USD  3.9  million  (30  June  2014:  USD  4.2  million)  represent  5.4 million  nursery  plants  (30  June  2014:  5.2  million).  Nursery  plants  are  carried  at  cost  as  it  is  deemed  to  have  limited biological   transformation.   Seedlings   from   nursery   plants   are   sold   to   farmers   upon   harvest   and   are   carried   at   a consistent  unit  cost.  

Notes  to  interim  financial  statements  (continued)     14.    Borrowings   31  December

30  June

2014

2014

USD'000

USD'000

Current -­‐                    Hire  purchase -­‐                    Term  loans

20

32

42,268

123,649

42,288

123,681

Non-­‐Current -­‐                    Hire  purchase -­‐                    Term  loans

Total  borrowings

25

36

67,490

2,133

67,515

2,169

109,803

125,850

  http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

11/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

  During   the   period,   the   Group   repaid   bank   loan   amounting   to   USD123   million,   in   line   with   previously   disclosed repayment   terms.   The   Group   then   drew   down   bank   loans   amounting   to   USD105   million   at   a   weighted   average effective  interest  rate  of  5%  per  annum.    The  proceeds  were  used  to  meet  working  capital.    

15.    Income  taxes

Income  tax  expense  is  recognised  based  on  management's  best  estimate  of  the  weighted  average  annual  income  tax rate  expected  for  the  full  financial  year.    The  Group  has  no  estimated  assessable  profit.     The  Company  was  granted  a  tax  assurance  certificate  dated  18  August  2007  under  the  Exempted  Undertakings  Tax Protection  Act  1966  pursuant  to  which  it  is  exempted  from  any  Bermuda  taxes  (other  than  local  property  taxes)  until 28  March  2016  which  was  extended  to  31  March  2035  following  the  enactment  of  the  Exempted  Undertakings  Tax Protection  Amendment  Act  2011.   A   subsidiary   of   the   Group,   PureCircle   Sdn   Bhd   (PCSB),   has   been   granted   the   Bio-­‐Nexus   Status   by   the   Malaysian Biotechnology   Corporation   Sdn   Bhd   in   which   PCSB   is   entitled   to   a   100%   income   tax   exemption   for   a   period   of   10 years  on  its  first  statutory  income  commencing  in  2009.    Upon  the  expiry  of  the  10-­‐year  incentive  period,  PCSB  will  be entitled   to   a   concessionary   tax   rate   of   20%   on   income   derived   from   qualifying   activities   for   a   further   period   of   10 years.     Another   subsidiary   of   the   Group,   PureCircle   (Jiangxi)   Co.   Ltd.   (PCJX),   has   also   been   granted   a   10%   exemption   on corporate   tax   from   1   January   2013   to   31   December   2020   by   Ganzhou   State   Tax   Revenue   Department   under   the Western  Ganzhou  State  Development  program.

Notes  to  interim  financial  statements  (continued)     16.            Share  capital  and  share  premium   Number of  shares

Ordinary shares

Share premium

Total

USD'000

USD'000

USD'000

164,722

16,472

163,240

179,712

5,000

500

42,963

43,463

6

1

48

49

Balance  at  31  December  2014

169,728

16,973

206,251

223,224

Balance  at  1  July  2013

164,602

16,460

162,898

179,358

12

2

41

43

164,614

16,462

162,939

179,401

'000 Balance  at  1  July  2014 Issuance  of  shares Exercise  of  share  options

Exercise  of  share  options Balance  at  31  December  2013

 

  In  November  2014,  the  Group  completed  a  placement  of  5  million  new  ordinary  shares  at  GBP5.50  per  share.  The placement  raised  USD43.5  million  in  cash,  net  of  expenses.

  17.            Earnings  per  share  

The   basic   earnings   per   share   is   calculated   by   dividing   the   loss   attributable   to   owners   of   the   Company   by   the weighted  average  number  of  ordinary  shares  in  issue  during  the  period. 6  months  ended 31  December Loss  attributable  to  equity  holders  of  the  Company  (USD'000) Weighted  average  number  of  ordinary  shares  in  issue  ('000) Basic  loss  per  share  (US  Cents)

31  December

2014

2013

(899)

(1,894)

166,041

164,616

(0.54)

(1.15)

 

 

Diluted   earnings   per   share   is   not   applicable   as   the   potential   ordinary   shares   under   the   Company's   Long   Term Incentive  Plan  would  have  an  anti-­‐dilutive  effect.

18.            Dividends   No  dividends  were  declared  or  paid  by  the  Company  during  the  interim  period.    

19.            Contingent  liabilities  and  capital  commitments   At   the   end   of   the   period,   there   are   no   material   contingent   liabilities   which,   upon   becoming   enforceable,   may   have http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

12/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

a  material  impact  on  the  financial  position  of  the  Group.   Capital   commitments   amounting   to   approximately   USD1.1million   is   approved   and   contracted   for,   these   are incurred  for  the  purchase  of  land  and  upgrading  of  plant  and  machinery  in  Malaysia.   Subsequent  to  the  period,  the  Group  approved  an  expansion  capital  expenditure  of  USD7.8  million.

Notes  to  interim  financial  statements  (continued)     20.            Events  after  the  end  of  the  reporting  period   There  were  no  events  that  had  a  material  impact  to  the  condensed  consolidated  interim  financial  statements  after the  end  of  the  reporting  period.   Please  refer  to  note  19  relating  to  post  balance  sheet  capital  expenditure  expansion.  

21.            Significant  related  party  transactions   (a)              Identities  of  related  parties:

The  Group  and  /  or  the  Company  have  related  party  relationships  with: (i)        its  subsidiaries  and  joint  ventures; (ii)      the  directors  who  are  the  key  management  personnel;  and (iii)  companies  in  which  certain  directors  are  common  directors  and  /  or  substantial  shareholders.                          The  following  transactions  were  carried  out  by  the  Group  during  the  period:   (b)              Related  parties (i)        Related  Parties

Sales  of  goods  to  jointly  controlled  entities

31  December 2014 USD'000

31  December 2013 USD'000

                               2,885

2,536

                                                       (ii)      Key  Management  Personnel   Key   management   includes   executive   and   non-­‐executive   directors.   The   compensation   paid   or   payable   to key  management  for  employee  services  is  shown  as  below:  

Paul  Selway-­‐Swift Magomet  Malsagov John  Robert  Slosar Olivier  Phillipe  Marie  Maes Peter  Lai  Hock  Meng

Christopher  Pratt William  Mitchell

Remuneration

31  December 2014 USD'000

31  December 2013 USD'000

84 279                                            -­‐     42 45 34 192 676

44 165 21 23 26 -­‐ 166 445

31  December 2014 USD'000 676

31  December 2013 USD'000 445

 

Notes  to  interim  financial  statements  (continued)     21.    Significant  related  party  transactions  (continued)   (b)              Related  parties  (Cont'd)   (ii)      Key  Management  Personnel  (Cont'd)                      Number  of  Ordinary  Shares  Of  USD0.10  Each At

http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

At

13/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate The  Company

1  July 2014

Bought

Sold

31  December 2014

Direct  Interests Paul  Selway-­‐Swift

                               202,300

Magomet  Malsagov

                     14,855,612

Christopher  Pratt

                               686,916

Olivier  Phillipe  Marie  Maes

                               408,210

Peter  Lai  Hock  Meng

                               191,400

William  Mitchell

                               910,890

                                      5,500                                   11,300                                       5,500                                   10,100                                       8,700                                   13,650

                                               -­‐    

                                     207,800

                                               -­‐    

                           14,866,912

                                               -­‐    

                                     692,416

                                               -­‐    

                                     418,310

                                               -­‐    

                                     200,100

                                               -­‐    

                                     924,540

      Number  of  Options  over  Ordinary  Shares  Of  USD0.10  Each

The  Company

At

At

1  July

31  December

2014

Award

Exercise

2014

Direct  Interests Magomet  Malsagov Christopher  Pratt

                               686,640                                                  -­‐    

Olivier  Phillipe  Marie Maes

                                       2,900

Peter  Lai  Hock  Meng

                                       3,200

William  Mitchell

                               529,170

                                      5,336                                       3,280                                       4,110                                       4,360                                       4,689

                                               -­‐    

                                     691,976

                                               -­‐    

                                             3,280

                               (2,900)

                                             4,110

                               (3,200)

                                             4,360

                                               -­‐    

                                     533,859

   

 

Independent  review  report  to  PureCircle  Limited     PureCircle  Limited (Incorporated in Bermuda) Registration No.: 40431     Introduction   We have been engaged by the Company to review the condensed consolidated interim financial statements for the six months ended 31 December 2014 set out on pages 4 to 19, which comprise the consolidated statement of comprehensive income, consolidated statement of financial position, consolidated statement of changes in equity, consolidated statement of cash flows and related notes.   Directors'  responsibilities   The condensed consolidated interim financial statements are the responsibility of, and have been approved by, http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

14/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

the directors of PureCircle Limited. The directors are responsible for preparing the condensed consolidated interim financial statements in accordance with the AIM Rules for Companies which require that the financial information must be presented and prepared in a form consistent with that which will be adopted in the Company's annual financial statements.   As disclosed in Note 2, the annual financial statements of the group are prepared in accordance with International Financial Reporting Standards. The condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting" ("IAS 34").   The maintenance and integrity of the PureCircle Limited website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the condensed consolidated interim financial statements since they were initially presented on the website.   Our  responsibility   Our responsibility is to express to the Company a conclusion on the condensed consolidated interim financial statements based on our review. This report, including the conclusion, has been prepared for and only for the Company for the purpose of preparing the condensed consolidated interim financial statements under IAS 34 and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.      

Independent  review  report  to  PureCircle  Limited  (continued)     PureCircle  Limited (Incorporated in Bermuda) Registration No.: 40431     Scope  of  review   We conducted our review in accordance with International Standard on Review Engagements 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.   Conclusion   Based on our review, nothing has come to our attention that causes us to believe that the condensed consolidated interim financial statements for the six months ended on 31 December 2014 are not prepared, in all material respects, in accordance with IAS 34.           PricewaterhouseCoopers (No. AF: 1146) Chartered Accountants http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

15/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

Kuala Lumpur Malaysia 16 March 2015

Corporate  Information  

BOARD  OF  DIRECTORS

 

Non-­‐executive  Chairman Paul  Selway-­‐Swift   Executive  Directors Magomet  Malsagov,  Chief  Executive William  Mitchell,  Chief  Financial  Officer   Non-­‐executive  Directors Peter  Lai  Hock  Meng Olivier  Maes Christopher  Pratt   Audit  Committee Peter  Lai  Hock  Meng  (Chairman) Olivier  Maes Christopher  Pratt   Remuneration  Committee Olivier  Maes  (Chairman) Paul  Selway-­‐Swift Christopher  Pratt   Nomination  Committee Paul  Selway-­‐Swift  (Chairman) Magomet  Malsagov Olivier  Maes

 

NOMINATED  ADVISERS

 

RFC  Ambrian  Limited Level  14,  19-­‐31  Pitt  Street Sydney  NSW  2000 Australia.

 

Level  28,  QV1  Building 250  St  George's  Terrace Perth  WA  6000 Australia.       CORPORATE  BROKERS

 

Macquarie  Capital  (Europe)  Limited Ropemaker  Place 28  Ropemaker  Street London  EC2Y  9HD United  Kingdom

 

Mirabaud  Securities  Limited 33  Grosvenor  Place London  SW1X  7HY United  Kingdom http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

16/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

 

Liberum  Capital  Limited Ropemaker  Place,  Level  12 25  Ropemaker  Street London  EC2Y  9LY United  Kingdom

 

AUDITORS

 

PricewaterhouseCoopers Chartered  Accountants Level  10,  1  Sentral Jalan  Travers,  Kuala  Lumpur  Sentral PO  Box  10192 50706  Kuala  Lumpur Malaysia

Shareholder  Information

  INTERNET   Investors  and  corporate  stakeholders   www.purecircle.com Consumers www.steviapurecircle.com Health  professionals,  customers,  policy  makers,  consumers                www.globalsteviainstitute.com   REGISTERED  OFFICE   Clarendon  House 2  Church  Street Hamilton  HM  11 Bermuda   CORPORATE  HEADQUARTERS  MALAYSIA   10th  Floor,  West  Wing Rohas  Perkasa No.  9  Jalan  P.  Ramlee 50250  Kuala  Lumpur,  Malaysia T                            +606  2166  2206 F                            +606  2166  2207 E                            [email protected]   INVESTOR  RELATIONS   Request  for  further  copies  of  the  annual  report  or  other  investor  relation  matters  should  be  addressed  to  PureCircle  office       SHARE  REGISTRAR   In  Jersey  (Shares) Computershare  Investor Services  (Jersey)  Limited Queensway  House,  Hilgrove  Street St  Helier,  Jersey JE1  1ES Channel  Islands     In  the  UK  (Depositary  Interests) Computershare  Investor  Services  plc The  Pavilions,  Bridgwater  Road Bristol  BS13  8AE,  United  Kingdom   ANNUAL  GENERAL  MEETING http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

17/18

3/16/2015

PureCircle Limited | Interim Results | FE InvestEgate

  The  Annual  General  Meeting  (AGM)  will  be  announced  following  publication  of  the  Group's  results  for  financial  year  2015.   2015  financial  year  and  corporate  calendar Half  year  end  31  December  2014 Year  end  30  June  2015  

This information is provided by RNS The company news service from the London Stock Exchange   END     IR SFISDMFISEID

http://www.investegate.co.uk/ArticlePrint.aspx?id=201503160700104720H

18/18